These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4594363)

  • 1. What abrogates heart transplant rejection in immunological enhancement?
    Davies DA; Alkins BJ
    Nature; 1974 Feb; 247(5439):294-6. PubMed ID: 4594363
    [No Abstract]   [Full Text] [Related]  

  • 2. Passive enhancement of mouse skin allografts. Specificity of the antiserum for major histocompatibility.
    Staines NA; Guy K; Davies DA
    Transplantation; 1974 Aug; 18(2):192-5. PubMed ID: 4602953
    [No Abstract]   [Full Text] [Related]  

  • 3. Complement-activating properties of some rat alloantibodies.
    Ruszkiewicz M
    Transplantation; 1975 Sep; 20(3):227-36. PubMed ID: 1080612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cell-dependent cytotoxicity as an assay for mouse alloantibody.
    Halloran P; Festenstein H
    Nature; 1974 Jul; 250(461):52-4. PubMed ID: 4135224
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of skin allograft rejection and cytotoxic antibody production in two lines of mice genetically selected for "high" and "low" antibody synthesis.
    Liacopoulos-Briot M; Bouthillier Y; Mouton D; Lambert F; Decreusefond C; Stiffel C; Biozzi G
    Transplantation; 1972 Nov; 14(5):590-6. PubMed ID: 4563199
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibodies in the serum and on the heart of dogs with cardiac allografts.
    Goldman BS; Shumak KH; Silver MD; Cartier J; Lixfeld W; Bigelow WG; Crookston JH
    Transplant Proc; 1971 Mar; 3(1):515-8. PubMed ID: 4937929
    [No Abstract]   [Full Text] [Related]  

  • 7. Transplantation tolerance and enhancement. Concepts and questions.
    Elkins WL; Hellström I; Hellström KE
    Transplantation; 1974 Jul; 18(1):38-45. PubMed ID: 4151912
    [No Abstract]   [Full Text] [Related]  

  • 8. Active or passive enhancement and allograft survival.
    Wilson RE
    Transplant Proc; 1972 Dec; 4(4):513-5. PubMed ID: 4405144
    [No Abstract]   [Full Text] [Related]  

  • 9. Allograft enhancement by treatment with donor antigens extracted from alloantisera immune complexes.
    Debray-Sachs M; Liegeois A; Arnould A
    Transplant Proc; 1977 Mar; 9(1):953-6. PubMed ID: 325827
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibodies and early human transplant rejection.
    De Planque BA; Williams GM; Borst-Eilers E; Hume D
    Transplant Proc; 1971 Mar; 3(1):376-9. PubMed ID: 4106325
    [No Abstract]   [Full Text] [Related]  

  • 11. Functional characterization of blocking antibody after human renal transplantation.
    Miller J; Lifton J; Rood F; Kyriakides G; Gajl-Peczalska KY; Yunis EJ; Hattler BG
    Surgery; 1974 Jul; 76(1):129-41. PubMed ID: 4135311
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of complement in the HL-A antibody-mediated lysis of lymphocytes.
    Ferrone S; Cooper NR; Pellegrino MA; Reisfeld RA
    Transplant Proc; 1974 Mar; 6(1):13-9. PubMed ID: 4856285
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of human F(ab') 2 fragments as blocking agents in the mixed lymphocyte reaction.
    Hornung MO; Layne E; McDonald JC
    J Immunol; 1971 Oct; 107(4):979-84. PubMed ID: 4999263
    [No Abstract]   [Full Text] [Related]  

  • 14. Fate of HL-A antigens and antibodies at the lymphocyte surface.
    Cullen SE; Bernoco D; Carbonara AO; Jacot-Guillarmod H; Trinchieri G; Ceppellini R
    Transplant Proc; 1973 Dec; 5(4):1835-47. PubMed ID: 4130085
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhancement of renal allografts in rats and man.
    French ME; Batchelor JR
    Transplant Rev; 1972; 13():115-41. PubMed ID: 4617352
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunological enhancement of renal allografts.
    Stuart FP; McKearn TJ; Fitch FW
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):53-8. PubMed ID: 4140597
    [No Abstract]   [Full Text] [Related]  

  • 17. A haemolytic spot test for the estimation of alloantibody against antigens of the major histocompatibility complex.
    Jensenius JC
    Transplantation; 1976 Nov; 22(5):415-9. PubMed ID: 793099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cardinal role for I-region antigens (Ia) in immunological enhancement, and the clinical implications.
    Davies DA; Staines NA
    Transplant Rev; 1976; 30():18-39. PubMed ID: 781923
    [No Abstract]   [Full Text] [Related]  

  • 19. France-transplant: kidney transplantation as a guide for bone-marrow grafting.
    Hors J; Busson M; Dausset J
    Transplant Proc; 1974 Dec; 6(4):421-8. PubMed ID: 4612893
    [No Abstract]   [Full Text] [Related]  

  • 20. The lymphocytotoxic reaction: the mechanism of rabbit complement action.
    Ferrone S; Cooper NR; Pellegrino MA; Reisfeld RA
    J Immunol; 1971 Oct; 107(4):939-47. PubMed ID: 4999260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.